Miracle Cure or Placebo? AI’s Current Impact on Healthcare

AI has long been pitched as medicine’s miracle cure — a technology that would transform drug discovery, revolutionize diagnostics, and streamline overstretched health systems. Yet for every bold promise, skeptics ask: is AI truly healing healthcare, or is it still closer to a placebo, impressive in theory, but with limited effect in practice?

This keynote invites the industry to confront that question head-on. From pharma labs using AI to accelerate clinical trials, to hospitals deploying AI in diagnostics and workflows, to insurers and startups experimenting with predictive analytics and virtual care - where is AI genuinely improving outcomes, and where is it still stuck in pilot mode?

The debate will go beyond case studies to the hard realities:

What proof do we have that AI is delivering measurable value?
What structural barriers (data, reimbursement, regulation) still stand in the way?
Could healthcare be approaching its “ChatGPT moment” — a tipping point where AI shifts from hype to everyday practice?
By putting hype to the test, this keynote asks the question on everyone’s mind: is AI the miracle medicine the industry has been waiting for, or just another dose of placebo?

15:00 – 15:25 Founder Series: Saving Doctors and upgrading Patient Care with Generative AI | Fireside Chat

Speakers:

• Lukas Saari, CEO & Co-founder, Tandem Health
• Moderator: Louise Gookey, Stage Host, 4YFN

15:25 – 16:00 Moving AI from Pilot Mode to Standard of Healthcare | Panel Discussion

Speakers:

• Jacky Abitbol, Partner, Cathay Innovation
• Jorge Juan Fernández Garcia, Chief Innovation Officer, Hospital Clinic Barcelona
• Malbinder Fagura, Global Transform Care Director, AstraZeneca
• Carmen Pauline Rios Benton, CEO & Founder, Dotomatic
• Moderator: Yolanda Puiggros Jimenezdeanta, ,